|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Alba Therapeutics Corp., of Indianapolis, was incorporated as a Delaware corporation that will develop and commercialize synthetic peptide therapeutics and drug delivery adjuvants with a focus on immunomodulation and inflammation, as applied to specialty pharmaceutical markets. The company's founding management team includes Blake Paterson as CEO. The management team and advisory board have been involved in the development of more than 10 therapeutic macromolecules, 10 small-molecule pharmaceuticals and 10 drug launches over the past 20 years.
o Avant Immunotherapeutics Inc., of Needham, Mass., said Phase II data reported at the International Conference on ...